Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Neoplasms × Crizotinib × Clear all

Status

Completed 2 Terminated 1 Recruiting 1 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1 Granuloma, Plasma Cell 1

Interventions

tucatinib 1 taletrectinib 1 nirogacestat 1 denileukin diftitox 1 copanlisib 1 atezolizumab 1 Crizotinib 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02473497 2024-06-26

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

Pfizer

No longer available

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡